Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

NCT02049190 is registered in ClinicalTrials.gov with Arno Therapeutics as lead sponsor.

NCT NCT02049190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02049190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Lead sponsor
Arno Therapeutics
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2014
Completion date
December 31, 2017
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen-independent prostate cancer, metastatic prostate cancer, prostate cancer, recurrent prostate cancer